BCR : Analysis & Opinions

  1. Zimmer (ZMH) Likely to Miss Estimates this Earnings Season - ...

    January 28, 2015
    Zimmer Holdings Inc. (ZMH) is scheduled to report its fourth-quarter 2014 results before the opening bell on Jan 29.
  2. Is Thermo Fisher (TMO) Poised to Surprise Q4 Earnings? - Analyst ...

    January 28, 2015
    Thermo Fisher Scientific, Inc. (TMO) is set to report its fourth-quarter and full year 2014 earnings numbers before the opening ...
  3. Will Mead Johnson (MJN) Disappoint Q4 Earnings Estimates? - Analyst ...

    January 27, 2015
    Notably, in three of the past four quarters, Mead Johnson's (MJN) earnings have outpaced the Zacks Consensus Estimate with ...
  4. Can CR Bard (BCR) Keep the Earnings Streak Alive in Q4? - Analyst ...

    January 27, 2015
    We expect CR Bard Inc. (BCR) to beat earnings when the company reports its fourth quarter and full year 2014 financial numbers ...
  5. CareFusion Banks on Pipeline Strength, Pricing Woes Remain - ...

    January 26, 2015
    We note that CareFusion Corp (CFN) highly relies on innovation to develop new and differentiated products.
  6. Can Illumina (ILMN) Keep the Earnings Streak Alive in Q4? - Analyst ...

    January 23, 2015
    Illumina (ILMN) now expects adjusted earnings per share for full year 2014 slightly above the top end of its previously announced ...
  7. Henry Schein to Expand in Animal Health with scil Acquisition ...

    January 20, 2015
    Henry Schein Inc. (HSIC) recently decided to acquire scil animal care company GmbH ??? an animal health laboratory and imaging ...
  8. Teleflex Collaborates with HealthTrust for ARROW Devices - Analyst ...

    January 15, 2015
    Teleflex Incorporated (TFX) recently announced a strategic agreement with HealthTrust covering PICC (peripherally inserted ...
  9. Henry Schein Expands Dental Practice Transition in Florida - ...

    January 15, 2015
    Henry Schein Inc. (HSIC), recently acquired Florida-based dental practice transition and brokerage company ADS Florida.
  10. Covidien's (COV) Stellarex DCB Gets CE Mark Approval - Analyst ...

    January 9, 2015
    Covidien plc's (COV) Stellarex DCB is designed to treat peripheral arterial disease (PAD) patients.
  11. AngioDynamics Beats Q2 Earnings by a Penny, Guides Up - Analyst ...

    January 9, 2015
    AngioDynamics Inc. (ANGO) reported second-quarter 2015 earnings of 17 cents per share, which beat the Zacks Consensus Estimate ...
  12. Medtronic's (MDT) IN.PACT Admiral DCB Wins FDA Go-Ahead - Analyst ...

    January 6, 2015
    Medtronic's (MDT) IN.PACT Admiral DCB helps in reopening narrowed or blocked arteries located in the upper leg of a peripheral ...
  13. Align Technology Poised on Q3 and Invisalign Strength - Analyst ...

    December 31, 2014
    On Dec 31, 2014, we issued an updated research report on Align Technology Inc. (ALGN).
  14. Align Technology: Now a Buy on Solid Q3, Invisalign Strength ...

    December 26, 2014
    On Dec 24, Zacks Investment Research upgraded Align Technology (ALGN) to a Zacks Rank #2 (Buy).
  15. AngioDynamics (ANGO) Hits 52-Week High on Positive View - Analyst ...

    December 18, 2014
    Shares of AngioDynamics Inc (ANGO) reached a 52-week high of $19.20 on Dec 17, 2014.
  16. CR Bard Strong on Acquisitions, FDA Nod for Lutonix DCB - Analyst ...

    December 17, 2014
    CR Bard's initiative to introduce its products in the emerging markets is delivering accretive returns, as the company continues ...
  17. C. R. Bard Inc. (BCR): New Analyst Report from Zacks Equity Research ...

    December 16, 2014
    C. R
  18. MedTech Defies Sequestration, M&As Steal the Show - Industry ...

    August 26, 2014
    MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
  19. MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook

    May 1, 2014
    MedTech's Partial Tax Repeal: Is It Enough? - Industry Outlook
  20. MedTech Industry Stock Update - Jan 2014 - Industry Outlook

    January 7, 2014
    MedTech Industry Stock Update - Jan 2014 - Industry Outlook
  21. MedTech Industry Stock Update - Sept 2013 - Industry Outlook

    September 10, 2013
    MedTech Industry Stock Update - Sept 2013 - Industry Outlook
  22. It Gets A Little Harder From Here For Covidien

    April 29, 2013
    Expectations are the bigger issue for Covidien, as underlying growth is still pretty good on a relative basis.
  23. AngioDynamics Still Struggling To Get Back On Track

    April 10, 2013
    Ongoing revenue growth struggles and eroding market share is making the deep-value case harder at AngioDynamics.
  24. ANGO Beats on EPS, Tweaks View - Analyst Blog

    January 4, 2013
    AngioDynamics Inc. (ANGO) reported adjusted earnings of 10 cents per share for the second quarter of fiscal 2013 ended November ...
  25. Endo Health Solutions Needs Some Solutions Of Its Own

    November 7, 2012
    Can Endo reestablish itself as a quality healthcare name?
  26. AngioDynamics Wins GPO Contract - Analyst Blog

    October 11, 2012
    Therapeutic and diagnostic devices maker AngioDynamics (ANGO) recently won a contract with HealthTrust Purchasing Group, ...
  27. Teleflex and Novation Team Up - Analyst Blog

    September 10, 2012
    Teleflex Incorporated (TFX), a global leader in medical devices used in critical care and surgery, was recently awarded an ...
  28. Slew of Product Recalls at Covidien - Analyst Blog

    August 24, 2012
    Recently, health care products major Covidien plc. (COV) has been hit by a number of product recalls, the most significant ...
  29. Becton Dickinson Safe And Steady

    June 13, 2012
    Becton stands out for having one of the clearest growth strategies in its field as well as a solid track record of delivering ...
  30. Covidien Promotes Zogenix's Product - Analyst Blog

    June 8, 2012
    The pharmaceutical unit of Covidien plc (COV) and Zogenix Inc. (ZGNX) have recently agreed to co-endorse a prescription medicine ...
  31. Covidien Reports, Ready To Spin Off Pharma

    May 4, 2012
    Covidien is looking to bridge its current valuation discount with a number of purer-play rivals.
  32. CareFusion: Is It Still Cheap?

    May 3, 2012
    The biggest concern investors have with CareFusion is its low return on invested capital. Until it creates higher free cash ...
  33. Modest But Predictable Growth At C.R. Bard

    April 26, 2012
    C.R. Bard is posting modest operational growth but there is ample downside protection.
  34. 2011 - Another Sick Year For Larger Med-Tech

    December 29, 2011
    Larger healthcare companies are still getting sickly returns in the market.
  35. Covidien Delivers Once Again

    November 21, 2011
    Covidien is overlooked and undervalued.
  36. Is Hologic A Coiled Spring?

    November 11, 2011
    Hologic looks cheap on even modest growth recovery expectations.
  37. If CareFusion Can Execute, This Is A Major Bargain

    November 9, 2011
    CareFusion has to make some improvements, but it could really reward investors.
  38. Endo And Forest – Dumpster-Diving In Pharma

    September 21, 2011
    Endo and Forest have problems; however, the valuations seem excessively low.
  39. BD Healthy, But No Great Bargain

    August 9, 2011
    BD is not the cheapest health care name, but it comes with a lot of quality.
  40. Covidien's Image Starting To Change

    August 3, 2011
    Find out why Covidien is much better than many investors assume.
  41. Heavily Shorted Stocks Near Their Highs

    March 21, 2011
    When hot stocks have high short interest, investors should pause and reexamine their thesis.
  42. Money To Be Made In Medical Devices

    September 22, 2010
    New advances in medical devices will not only help patients live better lives, but they'll power portfolios as well.
  43. Covidien Happy With Tyco Split

    March 3, 2010
    Projections for double-digit profit increases at Covidien would easily take care of any valuation concerns at current levels.
  44. Mid Cap Stocks That Have Been Left Behind

    May 15, 2009
    Despite the huge market rally over the last two months, there are several mid cap stocks that have not participated. Investors ...
  45. Mileage Matters More Than Muscle

    March 26, 2008
    Sometimes consistency produces better returns than undependable potential. Medical equipment company C.R. Bard is proof.
Trading Center